3-aminoisobutyric acid has been researched along with Alloxan Diabetes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Aktas, I; Gur, FM | 1 |
Aktaş, İ; Mehmet Gür, F | 1 |
Chen, Q; Gao, XY; Kang, YM; Li, YH; Shi, CX; Shu, XD; Wang, JJ; Xiong, XQ; Zhao, MX; Zhu, GQ | 1 |
3 other study(ies) available for 3-aminoisobutyric acid and Alloxan Diabetes
Article | Year |
---|---|
The ameliorative effects of thymoquinone and beta-aminoisobutyric acid on streptozotocin-induced diabetic cardiomyopathy.
Topics: Aminoisobutyric Acids; Animals; Benzoquinones; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Male; Rats; Rats, Sprague-Dawley | 2021 |
Hepato-protective effects of thymoquinone and beta-aminoisobutyric acid in streptozocin induced diabetic rats.
Topics: Aminoisobutyric Acids; Animals; Benzoquinones; Blood Glucose; Diabetes Mellitus, Experimental; Male; Rats; Streptozocin | 2022 |
β-aminoisobutyric acid attenuates hepatic endoplasmic reticulum stress and glucose/lipid metabolic disturbance in mice with type 2 diabetes.
Topics: Administration, Oral; Aminoisobutyric Acids; AMP-Activated Protein Kinases; Animals; Apoptosis; Blood Glucose; Blotting, Western; Carbohydrate Metabolism; Cholesterol; Diabetes Mellitus, Experimental; Diet, High-Fat; Endoplasmic Reticulum Stress; Glucosamine; Hep G2 Cells; Humans; Immunohistochemistry; Insulin Resistance; Lipid Metabolism; Liver; Mice; Phosphorylation; Real-Time Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Signal Transduction; Thapsigargin; Triglycerides; Tunicamycin | 2016 |